Literature DB >> 22980052

The epidemiology and pathophysiology of heart failure.

Shradha Rathi1, Prakash C Deedwania.   

Abstract

Heart failure (HF) remains a major growing public health problem in the United States. Despite extensive understanding of the mechanism at the molecular level and innovations in therapy, HF carries high morbidity and mortality rates, with frequent hospital admissions. In the Medicare population, HF is the leading cause for hospitalization, accounting for more than1 million admissions per year. The authors provide a review of the epidemiology and pathophysiology of HF. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22980052     DOI: 10.1016/j.mcna.2012.07.011

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  10 in total

Review 1.  The empirical foundations of telemedicine interventions for chronic disease management.

Authors:  Rashid L Bashshur; Gary W Shannon; Brian R Smith; Dale C Alverson; Nina Antoniotti; William G Barsan; Noura Bashshur; Edward M Brown; Molly J Coye; Charles R Doarn; Stewart Ferguson; Jim Grigsby; Elizabeth A Krupinski; Joseph C Kvedar; Jonathan Linkous; Ronald C Merrell; Thomas Nesbitt; Ronald Poropatich; Karen S Rheuban; Jay H Sanders; Andrew R Watson; Ronald S Weinstein; Peter Yellowlees
Journal:  Telemed J E Health       Date:  2014-06-26       Impact factor: 3.536

2.  Cost-effectiveness of heart failure therapies.

Authors:  Luis E Rohde; Eduardo G Bertoldi; Livia Goldraich; Carísi A Polanczyk
Journal:  Nat Rev Cardiol       Date:  2013-04-23       Impact factor: 32.419

3.  Cost-effectiveness of B-type natriuretic peptide-guided care in patients with heart failure: a systematic review.

Authors:  Abdosaleh Jafari; Aziz Rezapour; Marjan Hajahmadi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

4.  Association between plasma ADAMTS-7 levels and ventricular remodeling in patients with acute myocardial infarction.

Authors:  Wenjing Wu; Yifeng Zhou; Yiyang Li; Jiahui Li; Yuannan Ke; Yong Wang; Jingang Zheng
Journal:  Eur J Med Res       Date:  2015-03-21       Impact factor: 2.175

Review 5.  Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials.

Authors:  Ye Zhu; Xiang Gu; Chao Xu
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

Review 6.  Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review.

Authors:  Cecilie Hoeeg; Sabina Frljak; Abbas Ali Qayyum; Bojan Vrtovec; Jens Kastrup; Annette Ekblond; Bjarke Follin
Journal:  Biomedicines       Date:  2020-12-05

7.  Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance.

Authors:  Hani Essa; Lauren Walker; Kevin Mohee; Chukwuemeka Oguguo; Homeyra Douglas; Matthew Kahn; Archana Rao; Julie Bellieu; Justine Hadcroft; Nick Hartshorne-Evans; Janet Bliss; Asangaedem Akpan; Christopher Wong; Daniel J Cuthbertson; Rajiv Sankaranarayanan
Journal:  Open Heart       Date:  2022-07

8.  Influence of bilevel positive airway pressure on autonomic tone in hospitalized patients with decompensated heart failure.

Authors:  Diego Lacerda; Dirceu Costa; Michel Reis; Evelim Leal de F Dantas Gomes; Ivan Peres Costa; Audrey Borghi-Silva; Aline Marsico; Roberto Stirbulov; Ross Arena; Luciana Maria Malosá Sampaio
Journal:  J Phys Ther Sci       Date:  2016-01-30

9.  Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice.

Authors:  Mudit Mishra; Ilayaraja Muthuramu; Joseph Pierre Aboumsallem; Herman Kempen; Bart De Geest
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

10.  The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran.

Authors:  Aziz Rezapour; Andrew J Palmer; Vahid Alipour; Marjan Hajahmadi; Abdosaleh Jafari
Journal:  Cost Eff Resour Alloc       Date:  2021-12-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.